Calendario de promoción Axonics, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa Axonics, Inc.
Axonics, Inc., медицинская технологическая компания, занимается разработкой и коммерциализацией систем крестцовой нейромодуляции (SNM). Системы SNM компании используются для лечения пациентов с гиперактивным мочевым пузырем, включая недержание мочи и частоту позывов к мочеиспусканию, а также недержание кала и необструктивную задержку мочи. Его запатентованная перезаряжаемая система SNM (r-SNM) подает слабые электрические импульсы на целевой крестцовый нерв, чтобы восстановить нормальную связь с мозгом и от него, чтобы уменьшить симптомы дисфункции мочевого пузыря и кишечника. más detalles| IPO date | 2018-10-31 |
|---|---|
| ISIN | US05465P1012 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.axonics.com |
| Цена ао | 70.98 |
| Cambio de precio por día: | 0% (70.98) |
|---|---|
| Cambio de precio por semana.: | 0% (70.98) |
| Cambio de precio por mes: | 0% (70.98) |
| Cambio de precio en 3 meses.: | 0% (70.98) |
| Cambio de precio en seis meses: | +3.12% (68.83) |
| Cambio de precio por año: | +4.61% (67.85) |
| Cambio de precio en 3 años.: | +20.63% (58.84) |
| Cambio de precio en 5 años.: | +161.15% (27.18) |
| Cambio de precio en 10 años.: | 0% (70.98) |
| Cambio de precio desde principios de año.: | 0% (70.98) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Fecha de transacción | fecha de divulgación | Persona enterada | Tipo | Precio | Volumen | Cantidad | Comparte hasta, % | compartir después, % | Documento |
|---|---|---|---|---|---|---|---|---|---|
| 02.10.2024 | 03.10.2024 | Keese Kari Leigh Chief Financial Officer |
Venta | 69.41 | 205 523 | 2961 | 0 | -0.01 | enlace |
| 24.07.2024 | 25.07.2024 | COHEN RAYMOND W Chief Executive Officer |
Compra | 22.94 | 2 383 370 | 103896 | 0 | 0.22 | enlace |
| 31.01.2024 | 02.02.2024 | COHEN RAYMOND W Chief Executive Officer |
Venta | 67.74 | 2 381 810 | 35161 | 0 | -0.08 | enlace |
| 31.01.2024 | 02.02.2024 | COHEN RAYMOND W Chief Executive Officer |
Compra | 67.7 | 4 292 180 | 63400 | 0 | 0.14 | enlace |
| 31.01.2024 | 02.02.2024 | Keese Kari Leigh Chief Financial Officer |
Venta | 67.74 | 236 345 | 3489 | 0 | -0.01 | enlace |
| 31.01.2024 | 02.02.2024 | Keese Kari Leigh Chief Financial Officer |
Compra | 67.7 | 417 506 | 6167 | 0 | 0.01 | enlace |
| 31.01.2024 | 02.02.2024 | Ford Alfred J Jr Chief Commercial Officer |
Venta | 67.74 | 1 125 500 | 16615 | 0 | -0.04 | enlace |
| 31.01.2024 | 02.02.2024 | Ford Alfred J Jr Chief Commercial Officer |
Compra | 67.7 | 1 726 350 | 25500 | 0 | 0.06 | enlace |
| 31.01.2024 | 02.02.2024 | Woock John EVP, Chief Mktg/Strtgy Officer |
Venta | 67.74 | 1 077 000 | 15899 | 0 | -0.03 | enlace |
| 31.01.2024 | 02.02.2024 | Woock John EVP, Chief Mktg/Strtgy Officer |
Compra | 67.7 | 1 895 600 | 28000 | 0 | 0.06 | enlace |
| 31.01.2024 | 02.02.2024 | Noblett Karen Chief Medical Officer |
Venta | 67.74 | 764 649 | 11288 | 0 | -0.02 | enlace |
| 31.01.2024 | 02.02.2024 | Noblett Karen Chief Medical Officer |
Compra | 67.7 | 1 861 750 | 27500 | 0 | 0.06 | enlace |
| 31.01.2024 | 02.02.2024 | Sama Rinda Chief Operating Officer |
Compra | 67.7 | 1 895 600 | 28000 | 0 | 0.06 | enlace |
| 08.01.2024 | 10.01.2024 | Noblett Karen Chief Medical Officer |
Venta | 69 | 1 103 930 | 15999 | 0 | -0.03 | enlace |
| 28.07.2023 | 01.08.2023 | Ford Alfred J Jr Chief Commercial Officer |
Venta | 62.01 | 93 015 | 1500 | 0 | 0 | enlace |
| 26.05.2023 | 31.05.2023 | Dearen Danny L. President & CFO |
Venta | 49.46 | 395 631 | 7999 | 0 | -0.02 | enlace |
| 21.04.2023 | 25.04.2023 | Dearen Danny L. President & CFO |
Venta | 60.21 | 1 204 200 | 20000 | 0 | -0.04 | enlace |
| 21.04.2023 | 25.04.2023 | Dearen Danny L. President & CFO |
Compra | 14.19 | 187 422 | 13208 | 0 | 0.03 | enlace |
| 20.04.2023 | 24.04.2023 | Dearen Danny L. President & CFO |
Venta | 60.01 | 120 080 | 2001 | 0 | 0 | enlace |
| 20.04.2023 | 24.04.2023 | Dearen Danny L. President & CFO |
Compra | 14.19 | 28 394 | 2001 | 0 | 0 | enlace |
| 13.09.2022 | 15.09.2022 | Dearen Danny L. See Remarks |
Venta | 75.6 | 49 594 | 656 | 0 | 0 | enlace |
| 12.09.2022 | 20.09.2022 | Noblett Karen Chief Medical Officer |
Venta | 78.16 | 2 538 870 | 32483 | 0 | -0.07 | enlace |
| 12.09.2022 | 20.09.2022 | Noblett Karen Chief Medical Officer |
Compra | 19.19 | 623 349 | 32483 | 0 | 0.07 | enlace |
| 08.09.2022 | 12.09.2022 | Woock John Chief Marketing Officer |
Venta | 75 | 562 500 | 7500 | 0 | -0.02 | enlace |
| 08.09.2022 | 12.09.2022 | Woock John Chief Marketing Officer |
Compra | 1.52 | 11 400 | 7500 | 0 | 0.02 | enlace |
| 07.09.2022 | 09.09.2022 | Noblett Karen Chief Medical Officer |
Venta | 71.53 | 747 775 | 10454 | 0 | -0.02 | enlace |
| 25.08.2022 | 26.08.2022 | Woock John Chief Marketing Officer |
Venta | 72.95 | 547 125 | 7500 | 0 | -0.02 | enlace |
| 10.08.2022 | 12.08.2022 | Sama Rinda Chief Operating Officer |
Venta | 69.56 | 2 354 610 | 33850 | 0 | -0.07 | enlace |
| 10.08.2022 | 12.08.2022 | Sama Rinda Chief Operating Officer |
Compra | 17.04 | 576 804 | 33850 | 0 | 0.07 | enlace |
| 10.08.2022 | 12.08.2022 | Woock John Chief Marketing Officer |
Venta | 69.71 | 1 045 650 | 15000 | 0 | -0.03 | enlace |
| 10.08.2022 | 12.08.2022 | Woock John Chief Marketing Officer |
Compra | 1.63 | 12 225 | 7500 | 0 | 0.02 | enlace |
| 08.08.2022 | 10.08.2022 | COHEN RAYMOND W Chief Executive Officer |
Venta | 70.44 | 3 099 360 | 44000 | 0 | -0.1 | enlace |
| 05.07.2022 | 07.07.2022 | Kiernan Jane E Director |
Venta | 60 | 315 000 | 5250 | 0 | -0.01 | enlace |
| 01.04.2022 | 07.07.2022 | Kiernan Jane E Director |
Venta | 62.71 | 109 743 | 1750 | 0 | 0 | enlace |
| 29.03.2022 | 31.03.2022 | Kiernan Jane E Director |
Venta | 60.5 | 317 625 | 5250 | 0 | -0.01 | enlace |
| 29.03.2022 | 31.03.2022 | COHEN RAYMOND W Chief Executive Officer |
Venta | 60 | 3 000 000 | 50000 | 0 | -0.11 | enlace |
| 05.08.2021 | 07.07.2022 | Kiernan Jane E Director |
Compra | 24.88 | 352 475 | 14167 | 0 | 0.03 | enlace |
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Vanguard Group Inc | 5 | 9.88 |
| Blackrock Inc. | 4 | 8.4 |
| Alpine Associates Management Inc. | 2 | 3.56 |
| FIL LTD | 2 | 3.37 |
| Mackenzie Financial Corporation | 1 | 2.48 |
| State Street Corporation | 1 | 2.34 |
| Millennium Management LLC | 1 | 2.33 |
| Magnetar Financial LLC | 1 | 2.25 |
| Westchester Capital Management, LLC | 1 | 2.24 |
| Geode Capital Management, LLC | 1 | 2.23 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Mr. Raymond W. Cohen | CEO & Director | 1.71M | 1959 (66 años) |
| Mr. Rinda K. Sama | Chief Operating Officer | 902.83k | 1979 (46 años) |
| Mr. Alfred J. Ford Jr. | Chief Commercial Officer | 902.96k | 1971 (54 año) |
| Mr. Guangqiang Jiang Ph.D. | Chief Technology Officer | N/A | 1974 (51 año) |
| Mr. Neil Bhalodkar | Vice President of Investor Relations | N/A | |
| Mr. Aaron Pettit | General Counsel & Chief Compliance Officer | N/A | |
| Dr. John Woock Ph.D. | Executive VP, Chief Marketing & Strategy Officer | 902.83k | 1983 (42 año) |
| Mr. Michael V. Williamson Esq., J.D. | Senior VP, General & IP Counsel | N/A | 1972 (53 año) |
| Dr. Karen L. Noblett M.A.S., M.D. | Chief Medical Officer | 651.4k | 1963 (62 año) |
| Ms. Kari Keese | Chief Financial Officer | N/A | 1985 (40 años) |
DIRECCIÓN: United States, Irvine, CA , 26 Technology Drive - abrir en mapas de google, abrir mapas de Yandex
Sitio web: http://www.axonics.com
Sitio web: http://www.axonics.com
